The Cutting Edge of Cancer Innovation
Oncolytics Biotech Inc. is a developer of oncolytic viruses as cancer therapeutics and is listed on the Toronto Stock Exchange (TSX:ONC) and the NASDAQ (NASDAQ:ONCY). In addition to the information available on this site, investors can access the Company’s regulatory filings on the SEDAR website at www.sedar.com and on the EDGAR website at www.sec.gov.
Access our quarterly and year-end financial statements, MD&A, information circulars and annual reports.
View our stock charts and other information about our stock (TSX:ONC, NASDAQ:ONCY).
View Stock Information
Find out which analysts and institutions provide coverage of Oncolytics.
View Analyst Coverage